Skip to main content

AG

Stock
Materials
Silver

Performance overview

AG Price
Price Chart

Forward-looking statistics

Beta
0.93
Risk
58.97%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

first majestic silver corp. is committed to building a senior silver producing mining company based on an aggressive development and acquisition plan with a focus on mexico. the company presently owns and operates five producing silver mines in mexico.

Company info

SectorMaterials
IndustrySilver
Employees2K
Market cap$1.8B

Fundamentals

Enterprise value$4.2B
Revenue$698.5M
Revenue per employee—
Profit margin-12.32%
Debt to equity8.28

Security info

ExchangeNyse American
Type of shareCommon Stock
Earnings per share (EPS)-$0.28
Dividend per share$0.02
Revenue per share$2.07
Avg trading volume (30 day)$232M
Avg trading volume (10 day)$217M
Put-call ratio—

Macro factor sensitivity

Growth-4.5
Credit+9.0
Liquidity+0.6
Inflation-4.3
Commodities-1.6
Interest Rates-0.6

Valuation

Dividend yield0.27%
PEG Ratio32.54
Price to sales5.91
P/E Ratio32.54
Enterprise Value to Revenue6.06
Price to book1.69

Upcoming events

Next earnings dayAugust 1, 2025
Next dividend day—
Ex. dividend dayMay 16, 2025

News

These Analysts Cut Their Forecasts On Conagra Brands After Weak Q4 Earnings

ConAgra Brands, Inc. CAG posted disappointing Q4 results and issued a cautious outlook for fiscal 2026 on Thursday.

Benzinga (July 11, 2025)
Are You Looking for a High-Growth Dividend Stock?

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does Penske (PAG) have what it takes?

Zacks Investment Research (July 11, 2025)
Conagra Q4 Earnings Miss Estimates, Sales Decline 4.3% Y/Y

CAG misses Q4 estimates as sales dip 4.3% and EPS slides 8.2%. It eyes FY26 rebound with a focus on snacks and frozen food.

Zacks Investment Research (July 10, 2025)
Invest in These 5 Low Price-to-Sales Stocks Before They Take Off

Low P/S stocks like HG, GBX, SIG, CTSH and PAGS show strong value potential, backed by fundamentals and business momentum.

Zacks Investment Research (July 10, 2025)
Agios Pharmaceuticals (AGIO) Moves 7.7% Higher: Will This Strength Last?

Agios Pharmaceuticals (AGIO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Zacks Investment Research (July 10, 2025)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free